Abstract

Eleni Zika is currently a research program manager at the Medical Research Council (London, UK). Previously she was a research fellow in the 'Agriculture and Life Sciences in the Economy' unit of the Institute for Prospective Technological Studies of the European Commission, where her work focused on the socioeconomic impacts of biotechnology, including pharmacogenetics. Prior to that, she worked as a Christine Mirzayan Science and Technology Policy Fellow at the US National Academies (Washington DC, USA), where she performed research on the role of intellectual property in research innovation, particularly as related to genomics and proteomics. She received her PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill (NC, USA). Her graduate work focused on the regulation of immunity but also on the ethical, legal and social implications of genetics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.